|
You are here Biopharmaceutical/ Genomic Glossary homepage/Search > About genomic glossaries & taxonomies Scope & history How terms were chosen & defined About these
biopharmaceutical glossaries & taxonomies These glossaries & taxonomies are a project of Mary Chitty, Library Director at Cambridge Healthtech Institute. We try to follow new and evolving trends in biotechnology and biotech informatics, particularly those related to the pharmaceutical industry. Keeping up with new biotechnology and biopharmaceutical terminology is a challenge for everyone these days, including us! When I started this project it seemed as if the web was the only way to keep up with such rapidly changing concepts. But as I have worked on them since 1999 I have come to realize that while I keep adding content, what is here doesn't become out of date nearly as quickly as I expected, and a print version could be very useful. I'm actively looking for a publisher and offer the Concise Biopharmaceutical Glossary as a draft manuscript. Mary Chitty mchitty@healthtech.com Scope & Origins: These glossaries are
Technical Varying purposes demand different degrees of depth and preparation. By doing your homework, many subjects can become more accessible than they appear at first glance. Knowing how to ask informed questions is more important than seeming to know all the answers. Some questions clearly don't have complete answers yet. Not comprehensive
Not only for biologists or chemists – and not only for
scientists The pharmaceutical and biotechnology industries have become much more science (and information) driven in recent years, but the rate of change (both technological and cultural) can be pretty slow. Diffusion of Science Driven Drug Discovery Organizational Change in Pharmaceutical Research, Rebecca Henderson, Iain Cockburn and Scott Stern http://www.cid.harvard.edu/cidbiotech/events/henderson.htm Cutting edge technology demands considerable investment. Public- private collaborations are increasingly the way the biggest bioscience projects get done. Progress rarely happens as quickly as people want (or predict). Advances in molecular biology in the 1970's were responsible for the growing influence of biotechnology in the 1980's and 1990's -- and while genomics and proteomics have been more in the lab than in the clinic, hospital and health professionals' offices, this is very much in the process of changing. We all need to know more about how molecular biology will be influencing personal decisions - and public debate. Not authoritative or definitive Descriptive - not prescriptive definitions
Not primarily focused on clinical applications
I urge people using the web for finding information on medical issues to carefully and critically evaluate where the information is coming from, whether it is up to date (far too few websites clearly date information) and whether the provenance of information and suggestions for additional resources are clearly indicated. For more information on this too seldom discussed topic see Susan Detwiler's "Charlatans, Leeches, and Old Wives: Medical Misinformation" Searcher 9(3), Mar. 2001. http://www.infotoday.com/searcher/mar01/detwiler.htm
Not concentrated upon basic research These (relatively) short and selective (30 - 60+ definitions each, or 6 - 8+ printed pages, if you use the smallest type) glossaries are organized by subject. Some organizations, government agencies, and cryptic acronyms are included selectively. This website is not so much a dictionary, but a quickly scannable series of brief guides, arranged to provide suggestions for related and broader and narrower terms of possible interest. I know this needs to go into a database, and am working on that (slowly, given my limited/ non-existent budget). Neologisms
Hard(er) to find definitions
Categories Subtle nuances Unfamiliar technologies can be particularly intimidating to the uninitiated. Definitions of relevant technologies and instrumentation are provided, with various links and contexts. Some less familiar basic terms (but not particularly new technologies) may be included selectively. Old words, new meanings
Other terms have long been used by biologists, but are now in the process of evolving new meanings in a genomic context (gene, phenotype, genetic testing). Still others need a specific genomic context (profiling, scoring, or threading). While the central dogma (DNA makes RNA makes protein(s)) is clearly a continuum, the chasm between people (and technologies for) working with DNA and proteins is still vast. Origins
An early discussion of which terms to define for a report glossary led a CHI editor to suggest that any word in the text not in the standard spell checking software should be a candidate. This was said (only) half jokingly. As I began to research terms I was struck by how little overlap there was in genetic and proteomic terminology, and while the gap is narrowing it is still an issue. I had become interested in identifying terminology used by different specialties with variant meanings when I ran the first CHI Bioinformatics conference in San Francisco in June 1995 (originally started at Florida State University in 1991). Discussions of communication difficulties between biologists and computer scientists, and the lack of interoperability between various databases sounded very familiar to a librarian. These differences can be particularly elusive, since each group tends to assume the other is making the same assumptions about nuances and implications, usually without explicitly verifying those assumptions. Periodically I wonder if my own background has enough depth to support a project such as this glossary has become. Recently I was heartened while reading Horace Freeland Judson's Eighth Day of Creation: Makers of the Revolution in Biology (Cold Spring Harbor Laboratory Press 1996). Judson quotes James Watson talking about "the knowledge explosion in biology, the mass of facts you should probably know in order to move with some confidence ... is enormous... That's why it's nice if in some way we can put people into a position where they can begin to do science not much after twenty. It's a shame to wait any longer; even then, you see, you are groping, at first ... Probably what you should learn if you're a graduate student is, not large numbers of facts, especially if they're in books, but what the important problems are, and to sense - which experiments, work that's been done, probably" - he breathed in with a hiss - "probably aren't quite right. And which things you'd like to do yourself if a method came up to do it." (page 27) And it was comforting to read Ewan Birney's "disarmingly simple advice to scientists debuting in bioinformatics ... "Don't feel like an idiot, because everyone does when they first start"" [Declan Butler "Are you ready for the revolution? Nature 409(6822): 758-760, 15 Feb. 2001] I'm realizing that the variety of skills and domain expertise needed for breakthroughs in the life sciences is more than anyone discipline and/'or lifetime(s) can muster. While new technologies might be helpful, cultural shifts, incentives for collaborating, and pre-competitive cooperation will also be important. Incremental changes can be helpful more frequent than true paradigm shifts. Industrialization, scalability and automating and ramping up processes to move from the R&D lab into the clinic are under-appreciated challenges, as are marketing dilemmas that come about with disruptive technologies. Style guides [not necessarily followed] You might try Wikipedia http://en.wikipedia.org/wiki/Wikipedia:Manual_of_Style or the CDC Centers for Disease Control http://www.cdc.gov/ncidod/EID/style_guide_p2_3.htm Defining -- and understanding -- evolving terminology is an iterative process. The web is perhaps the only place to try to cover a field in such flux. Definitions are a work in progress. I look forward to receiving your comments, suggestions and questions. Mary Chitty mchitty@healthtech.com |
Contact
| Privacy Statement |
Alphabetical
Glossary List | Tips & glossary
FAQs | Site Map